The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.

January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA) is associated with more rapid, potentially dangerous growth in the aneurysm, according to a major study published Jan. 28 in the journal Radiology.[1] Researchers said the findings could help identify which patients need more aggressive treatment and more frequent follow-up imaging after their initial diagnosis.

The aorta is the major artery that carries oxygenated blood from the heart. Abdominal aneurysms occur when a bulge forms in the portion of the artery that runs through the abdomen. About 200,000 people in the U.S. are diagnosed with the condition every year. Over time, the wall can weaken and rupture. Ruptured abdominal aortic aneurysm is the 10th leading cause of death for men over age 55.

Decisions to surgically repair the aneurysm are based on its diameter. Patients with aneurysms larger than 5.5 cm are normally referred for repair, while those smaller than 5.5 cm are most commonly monitored with imaging at regular intervals. Ultrasound and cross-sectional imaging with CT or MRI are commonly used.

However, this diameter-based management strategy has limitations, as a considerable number of small aneurysms rupture, according to the study’s first author, Chengcheng Zhu, Ph.D., assistant researcher from the Department of Radiology and Biomedical Imaging at the University of California in San Francisco.

Zhu and colleagues focused their study on the intraluminal thrombus, a blood clot on the wall of the aorta at the location of the aneurysm. Intraluminal thrombi are present in the majority of aneurysms close to the repair threshold of 5.5 cm, and in a considerable number of smaller aneurysms. Despite their prevalence, the influence of these clots on abdominal aortic aneurysm growth and rupture risk is still not fully understood. 

“Intraluminal thrombus could be a new marker for aneurysm growth,” Zhu said.

The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.

Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.

“An aneurysm with thrombus grows much faster than one without a thrombus,” Zhu said. “Our study looked at a large number of patients with a relatively long follow-up to confirm that thrombus is a new risk factor that may be potentially reported by radiologists.”

While the study did not examine the reasons why the presence of a thrombus had such a dramatic impact on aneurysms, Zhu noted that it likely has harmful biochemical effects on the vessel wall.

“When the vessel wall is covered with thrombus, the lack of oxygen weakens the wall of the vessel, making the aneurysm likely to grow faster and rupture,” he explained.

The findings suggest that imaging follow-up schedules may need to be adjusted for patients whose aneurysm has a thrombus. Current protocols for follow-up imaging are based on aneurysm size and do not account for the absence or presence of a thrombus.

“A patient at high risk may need closer monitoring,” Zhu said. “If in patients with a thrombus the aneurysm grows twice as fast, then shortening the surveillance interval could be considered.”

Zhu said more research is needed before thrombus detection is integrated into clinical protocols. For now, he said the findings provide another piece of information to use in determining the prognosis of patients with this potentially dangerous condition.

 

Reference: 

1. Dr. Zhu were Joseph R. Leach, M.D., Ph.D., Yuting Wang, M.D., Warren Gasper, M.D., David Saloner, Ph.D., and Michael D. Hope, M.D. Intraluminal Thrombus Predicts Rapid Growth of Abdominal Aortic Aneurysms.” Radiology. Published Online: Jan 28 2020. https://doi.org/10.1148/radiol.2020191723.


Related Content

News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
Subscribe Now